OREGON FOCUSES ON GENERIC ANTIDEPRESSANTS
Third-party patients with new prescriptions for pricey antidepressant drugs will be encouraged to seek out cheaper generic versions under an innovative new "Generics First Antidepressant Program" initiated by Regence BlueCross BlueShield of Oregon. Noting that more generics are available today for patients suffering from depression, officials at Regence said that the "evidence indicates that most antidepressants are equally effective when comparable doses are used." Under the plan, Regence patients currently on the name-brand antidepressant drugs Cymbalta (duloxetine HCl), Lexapro (escitalopram oxalate), Paxil CR (paroxetine HCl), and Effexor XR (venlafaxine HCl) will not need prior authorization for continued coverage. Those with new prescriptions will, however.
"For members starting on one of the brand name antidepressants listed, Regence has asked physicians to prescribe a generic antidepressant such as citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, mirtazapine, or bupropion SR first," the company said. "These generics are a good value for members," as they cost an average of less than half the price of branded versions, according to Regence.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025